New Drug Cost Study: Canadian Online Pharmacies Offer Up to 89% Savings Versus GoodRx and Amazon for U.S. Consumers, Says Campaign for Personal Prescription Importation

Latest CPPI Data Shows Personal Drug Importation from Canada Provides More Affordable Medication Access; Could Prevent Dangerous Non-Adherence

original U.S. prescription drug costs continue to outpace affordability. This Drug Price Savings chart shows the significant cost discounts - between 52% and 89% - U.S. residents can expect when purchasing their prescription medications from licensed online Canadian pharmacies, compared to GoodRx and Amazon. This study was conducted in March 2026 by the Campaign for Personal Prescription Importation (PersonalImportation.org), a non-profit advocate for affordable access to prescription medications.

U.S. prescription drug costs continue to outpace affordability. This Drug Price Savings chart shows the significant cost discounts - between 52% and 89% - U.S. residents can expect when purchasing their prescription medications from licensed online Canadian pharmacies, compared to GoodRx and Amazon. This study was conducted in March 2026 by the Campaign for Personal Prescription Importation (PersonalImportation.org), a non-profit advocate for affordable access to prescription medications.

HILLSBOROUGH, N.J.--(BUSINESS WIRE)--The Campaign for Personal Prescription Importation (CPPI), a non-profit advocate for affordable access to prescription medications, has released a new price comparison study highlighting the stark differences between U.S. and Canadian pharmacy prices for popular brand-name prescription drugs.

We’re in an affordability epidemic. With the ability to personally import essentially identical medications from Canada, U.S. consumers can find desperately needed relief.
Share

Using data researched in Mar. 2026, CPPI’s analysis shows that for a sample of 10 popular, name-brand prescription medicines – all daily maintenance medications for common conditions – U.S. consumers can save 52% to 89% by purchasing from licensed Canadian online pharmacies. These results show personal importation from Canada continues to be a significant option for those facing exorbitantly high drug costs.

America in a Drug “Affordability Epidemic”
CPPI’s study underscores how U.S. prescription costs outpace affordability – as a great number of Americans are dangerously non-compliant with their drug therapy.

For instance, a recent survey from the Kaiser Family Foundation (KFF) reveals that about one in five adults (21%) have not filled a prescription due to cost.
Additionally, the KFF survey finds about one in seven adults say they have cut pills in half or skipped doses of medicine in the last year because of the cost.

“These results highlight the ongoing need for easily accessible alternatives to notoriously high U.S. pharmaceutical prices. We’re in an affordability epidemic,” said CPPI’s Executive Director Ken Hunter. “Millions of Americans are on fixed incomes, have high-deductible health plans that skyrocketed in price when Affordable Care Act subsidies ended in December, or can’t afford insurance at all. With the ability to personally import essentially identical medications from Canada, consumers can find desperately needed relief.”

CPPI’s findings, drawn from research comparing GoodRx and Amazon prices in the U.S. against Canadian equivalents, demonstrate average savings of over 64% across 10 commonly prescribed brand-name drugs. These include treatments for conditions including Type 2 diabetes, blood clots, and overactive bladder. Top savings examples for 90-day supplies include:

Jublia (12 ml, antifungal): U.S. GoodRx price $2,236.00, U.S. Amazon price $2,502.10, Canadian pharmacy average $257.77 – 89% savings.
Xifaxan (550 mg, treats IBS): U.S. GoodRx price $10,036.00, U.S. Amazon price $11,233.90, Canadian pharmacy average $2,325.78 – 78% savings.
Myrbetriq (50 mg, treats overactive bladder): U.S. GoodRx price $1,129.00, U.S. Amazon price $994.78, Canadian pharmacy average $314.57 – 70% savings.

Additional drugs researched in the study included Xarelto, Jardiance, Rybelsus, Farxiga, Trintellix, Premarin, and Eliquis. The full comparison chart of the 10 popular prescription medications is at https://shorturl.at/odDrW.

"With U.S. drug prices being less affordable for millions, this study shows personal prescription importation from licensed Canadian pharmacies remains a proven lifeline that is available today," said Hunter. "Our data shows consumers can slash costs on essential brand-name medications, allowing them to prioritize health without financial ruin. This transforms lives, and Americans should know they have this safe, reliable option."

For more information on safe importation and to join (for free) the fight for affordable medications, visit www.PersonalImportation.org.

Methodology:
Prices obtained Mar. 2026 for 90-day supplies. Amazon pricing is for delivery to N.J.; GoodRx pricing is from N.J. pharmacies using cash price with the lowest after-coupon discount price; Canadian mail-order pricing uses the average of a cross-section of pharmacies certified by Canadian International Pharmacy Assn. (CIPA.com) and is for Health Canada-approved, brand-name products dispensed by a pharmacy licensed in Canada. Savings based on average of GoodRx and Amazon prices. At time of survey, Rybelsus 7 mg was priced but unavailable at Amazon. All registered trademarks referred to herein belong to their respective owners.

About CPPI:
The Campaign for Personal Prescription Importation (CPPI), based in Hillsborough, N.J., is a national nonprofit patient advocacy organization fighting for Americans' access to safe, affordable prescription medications from Canada for personal use. Tens of millions of Americans – especially the elderly and others on fixed incomes – struggle to pay the extremely high prices of prescription medications in the U.S. CPPI is their voice. For more information and to join us: www.PersonalImportation.org.